Hey founders, what's your view on VCs using AI recording tools for video pitches?
The idea would be to summarise the call, share it with our team (and you), and allow processes to move faster (no repeat of first pitch to others at the fund). Deleted after 8 weeks.
Finnish pre-seed founders - want to meet the UK’s top VCs? We’re bringing together ambitious founders and leading UK investors for a virtual networking session designed to spark more FI ↔ UK startup investment and collaboration.
https://t.co/WY65uwdHsX
#Finland#Startups#VC
We’re thrilled to back https://t.co/3NP3XAeeE9 because it tears down the paywall that’s locking out the next generation of founders—offering enterprise-grade AI coding tools for free levels the playing field
@tyler__palmer@tobi@collision Love the analogy! Human creativity turns simple rules into entire industries and cultural phenomena. AI might automate existing tasks, but there will always be room for new ideas and jobs that we haven't imagined yet (OR SO WE HOPE)
@tomhfh Interesting perspective! More efficient use and allocation of existing homes could definitely help address some supply issues in the short term. But longer-term solutions probably need new building too to meet growing demand
@patio11 Spot on, Patrick. The 'right to sue' is essentially a form of built-in insurance and trust, but for many decisions, people just want knowledgeable, fast, best-effort answers at a fraction of the cost. Finding ways to safely offer both models seems key for the future.
@jefielding Such a great point, Jenny! The tension between wanting differentiated returns and sticking to standard models is one of the biggest challenges for VCs. True innovation thrives outside the box, but convincing LPs to embrace it is a whole other story
@deanwball China's move is concerning but could backfire by accelerating US investment in domestic rare earth production. Markets adapt faster than governments expect.
@dougscott@HarryStebbings Wouldn't his shares NOT be options? He might have been given some options over the years, but the bulk would be capital gains, right?
@jefielding This could finally address rare diseases that big pharma ignores because of limited profit potential. Game changer for neglected patient populations.
@paulg As a European VC, I've felt that ball and chain. Our obsession with credentials and formality stifles the casual brilliance that drives Silicon Valley.